Parkinsons Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with a possible diagnosis of Parkinsons disease made by a neurologist with expertise in PD and other movement disorders 2.Diagnosis of PD with Hoehn and Yahr stage I to II 3.Patients whose medication regimen has been stable for at least one month 4.Ability to walk independently for more than 10 meters 5.Male or female participants aged 18 years or older 6.Provision of written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients with dementia, defined as a Mini-Mental State Examination (MMSE) score of 24 or below 2.Patients unable to participate in consistent training or physical performance assessments due to alcohol or substance abuse, active depression, anxiety disorders, or psychosis 3.Patients with coexisting neurological or orthopedic conditions that interfere with mobility or exercise 4.Patients with a history of neurosurgical procedures 5.Patients with cardiovascular or pulmonary diseases that may interfere with the training 6.Patients who have participated in another clinical trial within the past six months 7.Any other condition that the principal investigator deems inappropriate for study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A sheet-type lower limb weight-bearing scale (WalkWay-MW-1000, Anima Co., Ltd.) was used for gait evaluation (walking speed) using a 10-meter walking test. | — |
Countries
Japan
Contacts
Kyushu University Hospital Department of Rehabilitation